Quantcast Acelity - Press Release Archive

Press Release Archive

2019 2ndQuarter

May 16, 2019
KCI Announces Significant Advancement in Negative Pressure Wound Therapy Drape Technology
Introducing DERMATAC™ Drape, the First-Ever FDA Cleared Silicone-Acrylic Hybrid NPWT Drape.
May 02, 2019
Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion
KCI is a leading global medical technology company focused on advanced wound care and specialty surgical applications.
April 18, 2019
KCI Files Registration Statement for Proposed Initial Public Offering
Acelity announced today that its affiliate, KCI Holdings, Inc. (“KCI”), filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”), relating to a proposed initial public offering of KCI’s common stock.
April 16, 2019
Acelity L.P. Inc. Announces New Senior Leadership Appointments
Acelity today announced Gaurav Agarwal, Chief Commercial Officer, has been promoted to the position of President and Chief Operating Officer.

2018 4thQuarter

December 07, 2018
KCI Introduces Latest Advancement in Negative Pressure Wound Therapy Designed Specifically for Multiple Traumatic Wounds
The V.A.C.RX4™ System is the result of a collaboration between KCI and the U.S. military; now available to meet the needs of trauma patients across the United States
November 12, 2018
Separate Independent Studies Found that PREVENA™ Therapy Reduced Complications Following Breast Cancer Surgery and Breast Reconstruction
Study findings indicate patients treated with PREVENA™ Therapy had lower postsurgical complication rates and shorter time to complete removal of drains compared with traditional gauze dressing

October 25, 2018
Data Demonstrate Proprietary Digital At-Home Monitoring Technology Increases Patient Adherence to NPWT

2018 3rdQuarter

September 13, 2018
Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare
Transaction to increase focus on innovation, development and commercialization of an expanded advanced wound dressings portfolio to better compete in this large and growing market

July 16, 2018
KCI Announces Availability of ABTHERA ADVANCE™ Open Abdomen Dressing
While under negative pressure, the unique configuration of the ABTHERA ADVANCE™ Perforated Foam collapses medially, actively drawing wound edges together
July 10, 2018
KCI Expands Offering of Next Generation Negative Pressure Wound Therapy Dressing
V.A.C. VERAFLO CLEANSE CHOICE™ Large Dressing allows for expanded use of dressing on larger complex wounds

2018 2ndQuarter

June 08, 2018
Acelity Acquires Crawford Healthcare to Create the World’s Most Expansive Wound Care Portfolio
Transaction adds complementary key product platforms, significant commercial scale and R&D expertise to Acelity

June 04, 2018
KCI Announces Addition to Leading Suite of Digital Wound Care Technologies with the Launch of Nurse2Nurse App Designed Specifically for Wound Care Nurses
This new online professional community underscores KCI’s commitment to leverage digital technology, connectivity and clinical education in order to advance the practice of wound care
April 30, 2018

2017 4thQuarter

November 27, 2017
New Independent Study Results add to Growing Body of Evidence that PREVENA™ Therapy Helps Reduce Surgical Site Infections and Complications
Study concludes that total arthroplasty patients treated with PREVENA™ Therapy were four times less likely to experience surgical site complications compared with traditional gauze dressing

2017 3rd Quarter

August 21, 2017
PREVENA™ Incision Management System Shown to Reduce Incisional Pain and Associated Narcotic Use Among Obese Study Patients Undergoing Cesarean Delivery
Study results indicate patients utilizing the PREVENA™ Incision Management System had a 30 percent decrease in opioid use during post-operative recovery and reduced surgical site occurrences

2017 2ndQuarter

June 23, 2017
Acelity Strengthens Global Commercial Leadership; names Ramesh Subrahmanian President for International Region
John McAuley appointed as Senior Vice President for Europe as company increases focus on markets beyond the United States

June 2, 2017
Thomas Jefferson University Researchers Recommend Negative Pressure Therapy Use for Groin Incisions Following Independent Study
New data demonstrates PREVENA™ Incision Management System may reduce reoperation, readmission and hospital costs for high-risk patients.

May 24, 2017
Acelity Launches PREVENA DUO™ Incision Management System Platform – the First Single-Use Negative Pressure Wound Therapy (NPWT) System for the Simultaneous Management of Two Incisions
Platform incorporates proven clinical benefits of PREVENA™ Therapy now available for the simultaneous management of two incisions.
April 13, 2017
Acelity Announces Enhancements to V.A.C.ULTA™ Therapy System
First-to-market connectivity and technology features reduce burden for hospital administrators and improve clinician ease-of-us

2017 1stQuarter

February 1, 2017
Acelity L.P. Inc. announced today that it has completed the sale of its regenerative medicine business unit, LifeCell Corporation, to Allergan for $2.9 billion in cash.

2016 4thQuarter

December 20, 2016

November 4, 2016
World Health Organization Issues New Guidelines Suggesting Use of Prophylactic Negative Pressure Wound Therapy to Reduce the Risk of Surgical Site Infections (SSIs)
Guidelines underscore the importance of negative pressure wound therapy in preventing costly SSI complications

October 26, 2016
Acelity Embarks Upon the Next Frontier in Advanced Wound Therapy with the Launch of a Telehealth Solution for the Home Care Setting
iOn PROGRESS™ Remote Therapy Monitoring delivers the first continuous monitoring and ready intervention for patients receiving negative pressure wound therapy in the home; supports patient compliance within lower-cost care setting

2016 3rdQuarter

September 20, 2016
Acelity Announces Early Tender Results for the Exchange Offer and Successful Completion of the Consent Solicitation with Respect to Senior Notes Due 2019

Acelity Announces Chief Financial Officer Transition Plan
Global Corporate Finance Vice President Todd Wyatt Named Interim CFO

September 7, 2016
Acelity Launches PREVENA PLUS™ Incision Management System with Customizable Dressing for a Range of Complex Procedures
The introduction of this new system offers surgeons the flexibility to bring the proven benefits of closed incision negative pressure therapy across different incision types
September 6, 2016
Acelity Announces Proposed Private Offering of $1,750 Million of Second Lien Senior Secured Notes

August 2, 2016
Acelity L.P. Inc. Reports Second Quarter and First Half Financial Results for 2016

July 28, 2016
Acelity To Offer New Gelling Fiber Advanced Wound Dressing
BIOSORB™ Gelling Fiber Dressing expands on the full range of Advanced Wound Dressings offered by Acelity and is now available in the U.S. with imminent availability in Europe

2016 2ndQuarter

June 17, 2016
May 3, 2016
ACELITY L.P. INC. reports first quarter financial results for 2016
Total Revenue for the First Quarter of 2016 Grows 3.0% on a Constant Currency Basis

April 13, 2016
Acelity Expands Wound Care Portfolio with Introduction of Advanced Foam Dressing Line in the U.S.
Seven new products now available from the TIELLE™ Foam Dressing Family complement extensive therapeutic options for chronic and acute wounds

2016 1st Quarter

February 16, 2016
Acelity and Mediq Partner to Strengthen Offering in Europe
Exclusive partnership will expand access to Acelity's advanced wound care and regenerative medicine portfolio for patients and clinicians in the Nordic Region
February 1, 2016
January 26, 2016
Acelity L.P. Inc. Reports Fourth Quarter and Full Year Financial Results for 2015
Total Revenue for the Fourth Quarter and Full Year of 2015 Grows 3.4% and 4.0%, respectively, on a Constant Currency Basis

2015 4thQuarter

December 1, 2015
Acelity Acquires SNAP® Disposable Negative Pressure Wound Therapy System to Expand Offering in Portable, Non-Powered NPWT Technology
Acquisition accelerates Acelity’s strategy in the disposable negative pressure wound therapy market

November 30, 2015
Acelity Increases Focus on Growth, Expansion Opportunities
Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing
November 18, 2015
Acelity Expands TIELLE™ Advanced Foam Dressing Portfolio in Europe
TIELLE Silicone Border combines proven absorption technology with a soft silicone adhesive; provides clinicians a new option to minimize pain and trauma for patients living with wounds

October 27, 2015
Acelity L.P. Inc. Reports Third Quarter and First Nine Months Financial Results for 2015
Total Revenue Grew 3.3% on a Constant Currency Basis
October 9, 2015
Acelity Deepens Commitment to Medical Education with Launch of Centres of Expertise Program in Europe
Collaborative program promotes clinician education and peer-to-peer exchange

October 8, 2015
Acelity Announces Expansion of PREVENA™ Therapy Portfolio with Addition of Shorter Peel & Place™ System
New system allows clinicians to better manage smaller incisions and anatomically challenging areas

2015 3rdQuarter
September 10, 2015
Acelity Advances Platform to Foster Innovation in Wound Care
North America Make Better Summit”unites healthcare innovators from the United States and Canada in order to deliver better outcomes

September 10, 2015
Acelity Partners with GHD to Expand Access to Advanced Wound Dressing Portfolio in Germany
Partnership increases Acelity’s Footprint in German Market

2015 2ndQuarter
June 11, 2015
Acelity Supports Education and Development of Early-Stage Surgeons
More than 350 Delegates Attend Acelity Surgical Wound Forum in Prague

May 1, 2015
Acelity Streamlines Patient Care with Launch of iOn HEALING™ Mobile App
New platform provides clinicians with direct access to Acelity solutions

2015 1stQuarter


2014 4thQuarter

September 3, 2014
KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity
Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue

2014 2ndQuarter

June 3, 2014
New Study Reported Prevena™ Therapy Patients had a Significantly Lower Infection Rate Following Cardiac Surgery Compared to Control Group
Surgical incision management could generate savings of more than 60 million Euros in Germany alone

2014 1stQuarter

March 5, 2014
Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy
Study Found Statistically Significant Reductions in OR Visits and Hospital Stay vs. Traditional V.A.C.® Therapy
January 14, 2014
October 28, 2013
KCI Completes Acquisition of Systagenix
Peter Huntley Appointed Senior Vice President and Leader of Systagenix

2013 3rdQuarter

Footer Navigation